Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma

Abstract Background we have recently shown that Tel-eVax, a genetic vaccine targeting dog telomerase (dTERT) and based on Adenovirus (Ad)/DNA Electro-Gene-Transfer (DNA–EGT) technology can induce strong immune response and increase overall survival (OS) of dogs affected by multicentric Diffuse Large...

Full description

Bibliographic Details
Main Authors: Joseph A. Impellizeri, Alessandra Gavazza, Eliana Greissworth, Anna Crispo, Maurizio Montella, Gennaro Ciliberto, George Lubas, Luigi Aurisicchio
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Journal of Translational Medicine
Subjects:
Cancer vaccine
Canine lymphoma
Genetic vaccine
TERT
Online Access:http://link.springer.com/article/10.1186/s12967-018-1738-6

Internet

http://link.springer.com/article/10.1186/s12967-018-1738-6

Similar Items